In a clinical research study headed by Dr. David Birch, scientists in the Rose-Silverthorne Retinal Degenerations Lab are testing the efficacy of gene therapy in patients with choroideremia. This late stage trial is based on early Phase 1 studies where over 90% of treated patients maintained or improved their vision over a one-year follow-up period. […]
READ MOREYi-Zhong Wang, Ph.D., Scientific Director, Macular Function Laboratory, is working to achieve automatic and accurate identification of defects in the structure of patients’ retinas by applying deep machine learning method. Over the past year, using a cutting-edge computer system, Dr. Wang has been training a deep convolutional neural network model to learn how to detect […]
READ MOREJenny Schisler has retinitis pigmentosa. Jenny wants to spread awareness of what having a visual impairment really means to her and others affected by retinal degenerative diseases. By Jenny Schisler There was recently a viral image of a visually impaired woman using a cane and looking at her phone. In ignorance, the typical person would […]
READ MOREThe Molecular Ophthalmology Laboratory, under the direction of Dr. Karl Csaky, Managing & Medical Director at the Retina Foundation of the Southwest, is studying live cell cultures to investigate new potential drug treatments for age-related macular degeneration (AMD). Live cultures offer a quick and scalable solution for testing new drugs and therapies for AMD. Here, […]
READ MOREThe Retina Foundation of the Southwest acquired and renovated a new clinical research center in Dallas, Texas thanks to tremendous help from the Board of Directors and generous support from foundations, companies, and individuals. Join us at the Open House after work Tuesday, April 23rd to celebrate the completion of the building campaign!
READ MOREThe Retina Foundation of the Southwest is pleased to announce the on-boarding of eight new Board members, who recently joined 19 existing members to oversee our efforts and ensure that we are working efficiently to advance our mission and reach our short-term and long-term goals. Mehmet Canas – UT Dallas Lois Carver – J.P. Morgan […]
READ MORESince 1982, the Retina Foundation of the Southwest has been researching pediatric eye conditions to help infants and children with lazy eye, crossed eyes, cataracts, and other conditions. On March 18, 2019, our 10,000th patient completed his appointment. All visits to the Retina Foundation of the Southwest are completely free of charge thanks to generous […]
READ MOREThe Retina Foundation of the Southwest and Rebion, a technology company in Boston, Massachusetts, created, evaluated, and received FDA approval for the Pediatric Vision Screener (PVS), a device that quickly and accurately evaluates the vision of children 2 to 6 years of age. The Pediatric Vision Scanner (PVS) has been cleared for use by primary […]
READ MOREThe Retina Foundation of the Southwest was the first site in the world to enroll patients in a new international Phase III Clinical Treatment Trial for Stargardt Disease sponsored by the clinical-stage ophthalmology company Acucela. This study is a phase III treatment trial to evaluate Acucela’s leading drug candidate, emixustat hydrochloride (“emixustat”), as a treatment […]
READ MORE
